Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Relapse after non-T-cell-depleted allogeneic bone marrow transplantation for chronic myelogenous leukemia: early transplantation, use of an unrelated donor, and chronic graft-versus- host disease are protective

H Enright, SM Davies, T DeFor, X Shu, D Weisdorf, W Miller, NK Ramsay, D Arthur, C Verfaillie, J Miller, J Kersey, P McGlave

Blood (1996) 88 (2): 714–720.

https://doi.org/10.1182/blood.V88.2.714.bloodjournal882714

Published: 1996

Journal Articles

Differentiation of natural killer (NK) cells from human primitive marrow progenitors in a stroma-based long-term culture system: identification of a CD34+7+ NK progenitor

JS Miller, KA Alley, P McGlave

Blood (1994) 83 (9): 2594–2601.

https://doi.org/10.1182/blood.V83.9.2594.2594

Published: 1994

Journal Articles

Unrelated donor marrow transplantation therapy for chronic myelogenous leukemia: initial experience of the National Marrow Donor Program

P McGlave, G Bartsch, C Anasetti, R Ash, P Beatty, J Gajewski, NA Kernan

Blood (1993) 81 (2): 543–550.

https://doi.org/10.1182/blood.V81.2.543.543

Published: 1993

Journal Articles

Role of monocytes in the expansion of human activated natural killer cells

JS Miller, S Oelkers, C Verfaillie, P McGlave

Blood (1992) 80 (9): 2221–2229.

https://doi.org/10.1182/blood.V80.9.2221.2221

Published: 1992

Journal Articles

The generation of human natural killer cells from CD34+/DR- primitive progenitors in long-term bone marrow culture

JS Miller, C Verfaillie, P McGlave

Blood (1992) 80 (9): 2182–2187.

https://doi.org/10.1182/blood.V80.9.2182.2182

Published: 1992

Journal Articles

Unrelated donor bone marrow transplantation for correction of lethal congenital immunodeficiencies

AH Filipovich, RS Shapiro, NK Ramsay, T Kim, B Blazar, J Kersey, P McGlave

Blood (1992) 80 (1): 270–276.

https://doi.org/10.1182/blood.V80.1.270.270

Published: 1992

Journal Articles

Acute- and chronic-phase chronic myelogenous leukemia colony-forming units are highly sensitive to the growth inhibitory effects of c-myb antisense oligodeoxynucleotides

MZ Ratajczak, N Hijiya, L Catani, K DeRiel, SM Luger, P McGlave, AM Gewirtz

Blood (1992) 79 (8): 1956–1961.

https://doi.org/10.1182/blood.V79.8.1956.1956

Published: 1992

Journal Articles

Adherent lymphokine-activated killer cells suppress autologous human normal bone marrow progenitors

JS Miller, C Verfaillie, P McGlave

Blood (1991) 77 (11): 2389–2395.

https://doi.org/10.1182/blood.V77.11.2389.2389

Published: 1991

Journal Articles

Leukemia inhibitory factor/human interleukin for DA cells: a growth factor that stimulates the in vitro development of multipotential human hematopoietic progenitors

C Verfaillie, P McGlave

Blood (1991) 77 (2): 263–270.

https://doi.org/10.1182/blood.V77.2.263.263

Published: 1991

Journal Articles

Diminished A-LAK cytotoxicity and proliferation accompany disease progression in chronic myelogenous leukemia

C Verfaillie, N Kay, W Miller, P McGlave

Blood (1990) 76 (2): 401–408.

https://doi.org/10.1182/blood.V76.2.401.401

Published: 1990

Journal Articles

Treatment of moderate/severe acute graft-versus-host disease after allogeneic bone marrow transplantation: an analysis of clinical risk features and outcome

D Weisdorf, R Haake, B Blazar, W Miller, P McGlave, N Ramsay, J Kersey, A Filipovich

Blood (1990) 75 (4): 1024–1030.

https://doi.org/10.1182/blood.V75.4.1024.1024

Published: 1990

Journal Articles

Adherent lymphokine-activated killer cells in chronic myelogenous leukemia: a benign cell population with potent cytotoxic activity

C Verfaillie, W Miller, N Kay, P McGlave

Blood (1989) 74 (2): 793–797.

https://doi.org/10.1182/blood.V74.2.793.793

Published: 1989

Journal Articles

Unrelated donor bone marrow transplantation therapy for chronic myelogenous leukemia

P McGlave, E Scott, N Ramsay, D Arthur, B Blazar, J McCullough, J Kersey

Blood (1987) 70 (3): 877–881.

https://doi.org/10.1182/blood.V70.3.877.877

Published: 1987

Journal Articles

Cytomegalovirus infection after bone marrow transplantation: an association with acute graft-v-host disease

W Miller, P Flynn, J McCullough, HH Jr Balfour, A Goldman, R Haake, P McGlave, N Ramsay, J Kersey

Blood (1986) 67 (4): 1162–1167.

https://doi.org/10.1182/blood.V67.4.1162.1162

Published: 1986

Journal Articles

Autologous bone marrow transplantation for patients with acute lymphoblastic leukemia in second or subsequent remission: results of bone marrow treated with monoclonal antibodies BA-1, BA-2, and BA-3 plus complement

N Ramsay, T LeBien, M Nesbit, P McGlave, D Weisdorf, P Kenyon, D Hurd, A Goldman, T Kim, J Kersey

Blood (1985) 66 (3): 508–513.

https://doi.org/10.1182/blood.V66.3.508.508

Published: 1985

Journal Articles

Bone marrow transplantation for acute nonlymphocytic leukemia in first remission: analysis of prognostic factors

B Bostrom, RD Brunning, P McGlave, N Ramsay, M Jr Nesbit, WG Woods, D Hurd, W Krivit, T Kim, A Goldman

Blood (1985) 65 (5): 1191–1196.

https://doi.org/10.1182/blood.V65.5.1191.1191

Published: 1985

Journal Articles

Total lymphoid irradiation and cyclophosphamide conditioning prior to bone marrow transplantation for patients with severe aplastic anemia

NK Ramsay, TH Kim, P McGlave, A Goldman, ME Jr Nesbit, W Krivit, WG Woods, JH Kersey

Blood (1983) 62 (3): 622–626.

https://doi.org/10.1182/blood.V62.3.622.622

Published: 1983

Journal Articles

Allogeneic bone marrow transplantation in acute nonlymphocytic leukemia: a pilot study

JH Kersey, NK Ramsay, T Kim, P McGlave, W Krivit, S Levitt, A Filipovich, W Woods, M O'Leary, P Coccia, ME Nesbit

Blood (1982) 60 (2): 400–403.

https://doi.org/10.1182/blood.V60.2.400.400

Published: 1982

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Relapse after non-T-cell-depleted allogeneic bone marrow transplantation for chronic myelogenous leukemia: early transplantation, use of an unrelated donor, and chronic graft-versus- host disease are protective

Differentiation of natural killer (NK) cells from human primitive marrow progenitors in a stroma-based long-term culture system: identification of a CD34+7+ NK progenitor

Unrelated donor marrow transplantation therapy for chronic myelogenous leukemia: initial experience of the National Marrow Donor Program

Role of monocytes in the expansion of human activated natural killer cells

The generation of human natural killer cells from CD34+/DR- primitive progenitors in long-term bone marrow culture

Unrelated donor bone marrow transplantation for correction of lethal congenital immunodeficiencies

Acute- and chronic-phase chronic myelogenous leukemia colony-forming units are highly sensitive to the growth inhibitory effects of c-myb antisense oligodeoxynucleotides

Adherent lymphokine-activated killer cells suppress autologous human normal bone marrow progenitors

Leukemia inhibitory factor/human interleukin for DA cells: a growth factor that stimulates the in vitro development of multipotential human hematopoietic progenitors

Diminished A-LAK cytotoxicity and proliferation accompany disease progression in chronic myelogenous leukemia

Treatment of moderate/severe acute graft-versus-host disease after allogeneic bone marrow transplantation: an analysis of clinical risk features and outcome

Adherent lymphokine-activated killer cells in chronic myelogenous leukemia: a benign cell population with potent cytotoxic activity

Unrelated donor bone marrow transplantation therapy for chronic myelogenous leukemia

Cytomegalovirus infection after bone marrow transplantation: an association with acute graft-v-host disease

Autologous bone marrow transplantation for patients with acute lymphoblastic leukemia in second or subsequent remission: results of bone marrow treated with monoclonal antibodies BA-1, BA-2, and BA-3 plus complement

Bone marrow transplantation for acute nonlymphocytic leukemia in first remission: analysis of prognostic factors

Total lymphoid irradiation and cyclophosphamide conditioning prior to bone marrow transplantation for patients with severe aplastic anemia

Allogeneic bone marrow transplantation in acute nonlymphocytic leukemia: a pilot study

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only